There you write:
“With the aid of a small team of specialists and in coordination with a renowned clinic, the medical approval procedure has been initiated. At its current progress, the Bimek SLV will receive market approval by 2023 for the European market.”
So, do you have the 1Million € now?
Will it be available in 2023?
Dear Andreas
Thank you for the question. We actually submitted the applications for the clinical study to the Federal Office for Drugs and Medical Devices (BfArM) in Germany in 2016. Unfortunately we could not find the financial means to carry it out. This state of affairs continues to this day as of the end of 2022. Since the clinical study will last at least 2 years, the schedule we specified at the time can no longer be maintained, even if we had the funds available today.
Kind regards
Clemens Bimek